Close Menu

NEW YORK (360Dx) – BioMérieux announced today that it has increased its holding in Suzhou Hybiome Biomedical Engineering, an immunoassay maker based in Suzhou, China.

The firm acquired a majority stake in Hybiome last year, and has now increased its stake from 54 percent to 67 percent, according to a statement.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.